Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 8—August 2024
Dispatch

ST913-IVa-t991 Methicillin-Resistant Staphylococcus aureus among Pediatric Patients, Israel

Moti BaumComments to Author , Einav Anuka, Maya Davidovich-Cohen, and Assaf Rokney
Author affiliation: Ministry of Health, Jerusalem, Israel

Main Article

Figure 3

Percentage of resistant isolates to antibacterial agents among 116 t991 MRSA isolates from Israel tested for antimicrobial susceptibility using the broth microdilution method. MRSA, methicillin-resistant Staphylococcus aureus.

Figure 3. Percentage of resistant isolates to antibacterial agents among 116 t991 MRSA isolates from Israel tested for antimicrobial susceptibility using the broth microdilution method. MRSA, methicillin-resistant Staphylococcus aureus.

Main Article

Page created: July 10, 2024
Page updated: July 21, 2024
Page reviewed: July 21, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external